ACHV · Nasdaq · CIK 0000949858

ACHIEVE LIFE SCIENCES, INC.

ACHIEVE LIFE SCIENCES, INC.’s most recent SEC filing in our snapshot is a Form 4 filed on Oct 6, 2026. Its EDGAR record lists 20 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2025
—
Net income, FY2025
-$54.6M
Form 4 filings on record, past 12 months
20

Company overview

Legal name (as filed)
ACHIEVE LIFE SCIENCES, INC.
Ticker
ACHV
SEC Central Index Key (CIK)
0000949858
Business address
SEATTLE, WA
State or country of incorporation
DE
Fiscal year ends
December 31
SEC filer category
Non-accelerated filer<br>Smaller reporting company
Position in SEC ticker list
#2718 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from ACHIEVE LIFE SCIENCES, INC.’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
n/aFY2021n/aFY2022n/aFY2023n/aFY2024n/aFY2025
Net income
-$33.2MFY2021-$42.4MFY2022-$29.8MFY2023-$39.8MFY2024-$54.6MFY2025
ACHV annual results
ItemFY2021
ended Dec 31, 2021		FY2022
ended Dec 31, 2022		FY2023
ended Dec 31, 2023		FY2024
ended Dec 31, 2024		FY2025
ended Dec 31, 2025
Revenue—————
Net income-$33.2M-$42.4M-$29.8M-$39.8M-$54.6M
Diluted EPS-$4.08-$4.00-$1.50-$1.24-$1.25
Total assets$47.5M$30.0M$19.4M$38.6M$41.8M
Cash and equivalents$43.0M$24.8M$15.5M$12.8M$20.9M

XBRL tags used: netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

ACHV latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Mar 24, 202610-KAnnual report· period Dec 31, 2025Document · Index
Aug 11, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Oct 1, 20268-KDirector or officer change· period Oct 1, 2026Document · Index
Jun 8, 2026DEF 14ADefinitive proxy statement· period Jun 8, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about ACHIEVE LIFE SCIENCES, INC., by form type:

4 ×128-K ×63 ×4SCHEDULE 13G ×410-Q ×2SCHEDULE 13G/A ×2144 ×1424B5 ×1ARS ×1DEF 14A ×1PRE 14A ×1EFFECT ×1CORRESP ×1UPLOAD ×1S-8 ×1S-3 ×1
ACHV recent filings
FiledFormWhat it isOriginal
Oct 6, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 5, 2026Document · Index
Oct 6, 20263Initial statement of beneficial ownership· period Oct 5, 2026Document · Index
Oct 1, 20268-KDirector or officer change· period Oct 1, 2026Document · Index
Aug 21, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 19, 2026Document · Index
Aug 19, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 17, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Aug 14, 20268-KOther events· period Aug 14, 2026Document · Index
Aug 14, 2026424B5424B5Document · Index
Aug 13, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Aug 11, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Aug 11, 20268-KResults of operations· period Aug 11, 2026Document · Index
Jul 29, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 27, 2026Document · Index
Jul 29, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 27, 2026Document · Index
Jul 29, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 27, 2026Document · Index
Jul 29, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 27, 2026Document · Index
Jul 29, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 27, 2026Document · Index
Jul 29, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 27, 2026Document · Index
Jul 29, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 27, 2026Document · Index
Jul 28, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Jul 27, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Jul 8, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Jul 6, 20268-KCharter, bylaws or fiscal year change; Shareholder vote results· period Jul 2, 2026Document · Index
Jun 8, 2026ARSARS· period Dec 31, 2025Document · Index
Jun 8, 2026DEF 14ADefinitive proxy statement· period Jun 8, 2026Document · Index
Jun 2, 20264Statement of changes in beneficial ownership (insider trade)· period May 29, 2026Document · Index
Jun 2, 20263Initial statement of beneficial ownership· period May 29, 2026Document · Index
Jun 2, 20264Statement of changes in beneficial ownership (insider trade)· period May 29, 2026Document · Index
Jun 2, 20263Initial statement of beneficial ownership· period May 29, 2026Document · Index
Jun 2, 20268-KDirector or officer change· period May 29, 2026Document · Index
May 29, 2026PRE 14APRE 14A· period May 29, 2026Document · Index
May 21, 2026EFFECTEFFECTDocument · Index
May 19, 2026CORRESPCORRESPDocument · Index
May 18, 2026UPLOADUPLOADDocument · Index
May 13, 20264Statement of changes in beneficial ownership (insider trade)· period May 11, 2026Document · Index
May 13, 20263Initial statement of beneficial ownership· period May 11, 2026Document · Index
May 12, 2026S-8Registration of employee benefit plan securitiesDocument · Index
May 12, 2026S-3Simplified registration statementDocument · Index
May 12, 202610-QQuarterly report· period Mar 31, 2026Document · Index
May 12, 20268-KResults of operations; Director or officer change· period May 7, 2026Document · Index
May 7, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index

Insider filing activity

20 Form 4 filings appear in ACHIEVE LIFE SCIENCES, INC.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in In Vitro & In Vivo Diagnostic Substances

All 8 companies in In Vitro & In Vivo Diagnostic Substances· Companies headquartered in Washington

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Electronics Plaud Note Pro AI Voice Recorder An AI voice recorder that turns earnings calls and meetings into notes. View on Amazon → Electronics Amazon Kindle Paperwhite Signature Edition 32GB Read investing classics and long reports without eye strain. View on Amazon → Electronics Apple 2026 MacBook Air 13-inch Laptop A lightweight laptop for spreadsheets and filing research. View on Amazon →

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0000949858 and XBRL company facts. ACHIEVE LIFE SCIENCES, INC. on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.